Second, further investigation supports the hypothesis that knockdown of circMMP11 inhibits the malignant characteristics of HCC cells by acting as a miRNA sponge for miR-361-3p through the inhibition of HMGB1, thereby providing a new therapeutic target for HCC. Here, HMGB1 is linked to hepatocellular carcinoma.